Trial Profile
Astagraf XL to Understand the Impact of Immunosuppression on De Novo DSA Development and Chronic Immune Activation in Kidney Transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- Acronyms ASTOUND
- Sponsors Astellas Pharma Global Development
- 03 Jun 2020 Results presented at the 2020 American Transplant Congress
- 01 Jul 2019 Status changed from active, no longer recruiting to completed.
- 12 Jun 2019 Planned End Date changed from 1 Mar 2020 to 1 Jun 2019.